While Bruton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Focusing on mantle cell lymphoma, Lori A. Leslie, MD, reviews the primary analysis of the SYMPATICO trial investigating ibrutinib-venetoclax combination therapy.

Lori leslieJamesk mccloskeyGloria leslieHackensack university medical centerJohn theurer cancer centerResearch programsPeer exchangeHackensack university medicalAssociate professorIndolent lymphomaWhile brutonMash 2023Sympatico studySympatico trialMantle cell lymphomaBtk inhibitors